Clinical Trials to Treat Thymoma and Thymic Carcinoma

Trials 1-9 of 9

A Study of Intensity-Modulated Pleural Radiation Therapy in People with Thymic Cancer That Has Spread to the Lining of the Lungs and Chest
Status: Active
Location: 7 locations
Ivonescimab for the Treatment of Thymic Cancer
Status: Active
Location: 5 locations
Sacituzumab Govitecan-Hziy for the Treatment of Patients with Advanced Thymoma or Thymic Carcinoma
Status: Active
Location: 3 locations
PT-112 in Subjects With Thymoma and Thymic Carcinoma
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Indocyanine Green for Imaging of Solid Tumors during Surgery Compared to Standard of Care
Status: Active
Location: University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania
Pembrolizumab in Treating Participants with Unresectable Thymoma or Thymic Cancer
Status: Active
Location: UT MD Anderson Cancer Center, Houston, Texas
The Cardiac Radiation Therapy Sparing for Thoracic Cancers, HEARTS Trial
Status: Active
Location: University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin
A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX43 in Advanced/Metastatic Solid Tumors
Status: Enrolling by Invitation
Location: 5 locations